Stockpolly
Search
CTNM · NASDAQ · Biotechnology

Contineum Therapeutics (CTNM)

Discovers and develops oral small-molecule therapies for neuroscience, inflammation and immunology.

$17.24
At close+0.69 (+4.14%)
Watchlist

Something off on this page? Send us feedback.

Next report
Oct 29, 2026
estimated · in 56 days
EPS estimate
−$0.45
Revenue estimate
$5.7M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Oct '25Mar '26May '26Jul '26Oct '26
Reported−$0.56−$0.62−$0.62−$0.45−$0.49−$0.39−$0.40Pending
Estimate−$0.44−$0.56−$0.56−$0.58−$0.50−$0.55−$0.45−$0.45
Surprise−27.3%−10.7%−10.7%+22.4%+2.0%+29.1%+10.9%—

RevenueReportedEstimate

Mar '25May '25Aug '25Oct '25Mar '26May '26Jul '26Oct '26
Reported———————Pending
Estimate—$6.0M$7.5M$5.0M$7.5M——$5.7M
Surprise————————

History

DateEstimateReportedSurprise
Oct 2026−$0.45——
Jul 2026−$0.45−$0.40+10.9%
May 2026−$0.55−$0.39+29.1%
Mar 2026−$0.50−$0.49+2.0%
Oct 2025−$0.58−$0.45+22.4%

The latest year is open to everyone — the 11 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Dec 2022
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Oct 29, 2026−$0.45——$5.7M———
Jul 30, 2026−$0.45−$0.40+10.9%———−1.7%
May 5, 2026−$0.55−$0.39+29.1%———+3.8%
Mar 5, 2026−$0.50−$0.49+2.0%$7.5M——+0.5%
Oct 30, 2025−$0.58−$0.45+22.4%$5.0M——+4.5%

The latest year is open to everyone — the 11 quarters behind it read with an account.

Sign in
Aug 5, 2025
May 14, 2025
Mar 6, 2025
Nov 6, 2024
Aug 13, 2024
May 16, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022